ArticleFrontiers in immunology2025
Epidemiological characteristics of breakthrough varicella cases among students in Jiulongpo District, Chongqing: implications for vaccination strategies.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effectiveness of varicella vaccine during a varicella outbreak in a Chinese senior high school: a retrospective cohort study.Frontiers in immunology · 2026Article
- Epidemiological characteristics and incidence prediction of varicella from 2014 to 2023 in Chongqing, China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the epidemiological characteristics and determinants of breakthrough varicella (BV) cases in student populations, identify key factors influencing breakthrough infection intervals, and provide recommendations for vaccination strategy optimization. Methods: A retrospective analysis was conducted on varicella cases and vaccination records among students in Jiulongpo District, Chongqing (2019-2023). Descriptive epidemiology methods were employed to characterize BV cases, with linear regression modeling assessing correlations between post-vaccination breakthrough intervals, primary immunization age, and the interval between two doses. Results: Among 970 BV cases (27.25% of total cases), significant difference was observed: (1) Temporal distribution exhibited bimodal epidemic peaks (May-June and October-December), with seasonal variation in breakthrough proportions (spring 28.35%, summer 25.33%, autumn 29.67%, winter 23.97%); (2) Geographic analysis revealed differential distribution across urban (28.07%), urban-rural fringe (23.04%), and rural areas (28.97%); (3) Population stratification showed highest proportions in kindergarten children (37.45%), followed by primary school (33.63%), middle school (24.75%), and high school students (6.87%). The linear regression analysis demonstrated that single-dose BV cases showed a negative correlation between post-vaccination breakthrough interval and primary immunization age (r=-0.384, P<0.05); two-dose BV cases exhibited dual negative correlations with both primary immunization age (r=-0.225, P<0.05) and the interval between two doses (r=-0.228, P<0.05). Conclusion: The rising incidence of varicella breakthrough infections necessitates transitioning to a two-dose regimen. To reduce the risk of breakthrough infections in student populations, we recommend timely administration of the first varicella vaccine dose at 12 months of age, followed by a second booster dose as early as possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.